Schedule 13G ownership disclosure
REGULUS THERAPEUTICS INC
Security class unavailable · CUSIP: 75915K200
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,155,516
- Percent of class
- 5.7100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001040188-24-000018
- Form type
- SC 13G
- Filer
- Regulus Therapeutics Inc.
- CIK
- CIK 1505512
- Filed
- Feb 06, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership